What is igm biosciences? IGM Biosciences, Inc. is a biotechnology company pioneering the development of engineered IgM antibodies. IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies.Is igm biosciences listed on the nyse or nasdaq? IGM Biosciences, Inc. is currently listed on NASDAQ under IGMS. One share of IGMS stock can currently be purchased for approximately $ 72.86. Is IGM Biosciences, Inc. listed on the NASDAQ or NYSE?What is igm biosciences revenue estimate for 2021? IGM Biosciences, Inc.’s revenue estimate for 2021 is $0. The latest low revenue estimate is $0 and the high revenue estimate is $0. Learn more about IGM Biosciences, Inc.’s revenue estimate.What are engineered igm antibodies? We are a biotechnology company pioneering the development of engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic applications.
Obtain the company profile for IGM BIOSCIENCES in MOUNTAIN VIEW, CA. Access business research with D&B Business Directory at DandB.com.